H1N1 Session Spotlights Newest Data, Best Defenses Against Pandemic
Today, 1:30 to 4 p.m. in Room 243-245 on the second level of the Morial Convention Center
In the 13 months
since the first cases of H1N1 influenza were reported, the world's medical community
has been collecting data on the epidemiology of the disease, its impact on the
population, its resistance to some anti-virals and treatment strategies that
are most effective.
With that in
mind, "2009 H1N1 Pandemic Influenza, A Year Later: The Current State of
Knowledge," is a must-attend session for ATS International Conference attendees
looking for the latest information on the H1N1 virus, which has become a
A host of
experts will inform attendees of developments that they may not have yet heard
about, said Lewis Rubinson, M.D., Ph.D., a senior medical advisor in the U.S.
Department of Health and Human Services (HHS) Office of the Assistant Secretary
for Preparedness and Response.
"I think the
strength of this year's symposium is the cast of international experts who are very familiar with H1N1,
several of whom have based their careers on the study of influenza," said Dr.
Rubinson, who will co-chair the session with Richard J. Whitley, M.D.,
professor of pediatrics, microbiology, medicine and neurosurgery at the
University of Alabama, Birmingham. "These speakers are considered some of the
most knowledgeable flu experts in the world and will be able to provide us with
an informed summary of H1N1 in 2009."
For those who
attended the symposium at ATS 2009 that addressed the emerging virus, the 2010
session will provide a more comprehensive overview of H1N1, as well as an
update as to what scientists now know about the disease.
"The data that
was available in May 2009 were not very accessible to most people," said Dr.
Rubinson, who is on faculty at the University of Washington Harborview Medical
Center, Seattle. "Now that we're further along in the pandemic, we know more
about the overall epidemiology of H1N1."
the ATS Assemblies on Environmental & Occupational Health and Microbiology,
Tuberculosis & Pulmonary Infections, the session will look at
H1N1-associated critical illness in adults and children using information
provided by the HHS H1N1 Critical Illness Registry. Subsequent talks will focus
on prevention—vaccines and anti-virals—and treatment—anti-virals and salvage
therapy—for H1N1-induced acute hypoxemic respiratory failure (AHRF).
M.D., deputy chief of the Epidemiology and Prevention Branch in the Centers for
Disease Control and Prevention's Influenza Division, will present "Summary of
2009 H1N1: Epidemiology, Disease Impact, Antiviral Resistance and Diagnostic
"Tim is a
world-renowned influenza clinical expert," Dr. Rubinson said. "He will talk
about the epidemiology and resistance of the virus, as well as how it has
slightly changed over the past year."
Thompson, M.D., who is associate professor of medicine at Harvard Medical
School and director of the Medical Intensive Care Unit at Massachusetts General
Hospital in Boston, will present "2009 H1N1-Associated Critical Illness in
Adults." Adrienne Randolph, M.D., an
associate professor of anesthesia and the director of the RSV and Asthma
Research Study Center at Children's Hospital, Boston, will discuss critical
illness in children caused by H1N1.
"Summary of 2009
H1N1 Treatments" will be presented by Frederick G. Hayden, M.D., a professor of
internal medicine and pathology in the Division of Infectious Diseases at the
"No matter who
puts together a short list of people that they'd like to have come speak about
the flu, Dr. Hayden is always there at the top," Dr. Rubinson said. "Fred has
more information on the flu in his pinkie than most of us can ever hope to
know. He will focus on the latest information in terms of what is known and not
known regarding treating the virus."
Busse, M.D., professor of medicine, allergy, pulmonary and critical care
medicine in the Department of Medicine at the University of Wisconsin School of
Medicine and Public Health, will then talk about the effect of severe asthma on
the immune response to H1N1 immunization.
co-moderators will end the session, with Dr. Whitley focusing on prevention
strategies, followed by Dr. Rubinson, who will talk about H1N1 severe hypoxemic
respiratory failure and the use and effectiveness of salvage therapies in 2009.